Search This Blog

Tuesday, August 7, 2018

Cara Therapeutics reports Q2 EPS (52c), consensus (32c)


Reports Q2 revenue $2.87M, consensus $6.47M.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)